Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Newly Diagnosed High Grade Glioma × Lomustine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 5 Brain Neoplasms 4 Glioma 3 Central Nervous System Neoplasms 2 Astrocytoma 2 Oligodendroglioma 1 Newly Diagnosed High Grade Glioma 1 Neoplasms 1 Melanoma 1 Medulloblastoma 1 Lymphoma, Follicular 1 Gliosarcoma 1 Familial ependymoma 1 Ependymoma 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Temozolomide 1 Nivolumab 1 Lomustine 1 Ipilimumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03425292 2023-11-08

A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer

Saint John's Cancer Institute

Phase 1 Completed

Newly Diagnosed High Grade Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡